Maximus, Inc. $MMS Shares Sold by Mackenzie Financial Corp

Mackenzie Financial Corp decreased its holdings in Maximus, Inc. (NYSE:MMS) by 10.1% during the 3rd quarter, HoldingsChannel reports. The fund owned 2,249,086 shares of the health services provider’s stock after selling 253,339 shares during the quarter. Mackenzie Financial Corp’s holdings in Maximus were worth $205,499,000 as of its most recent SEC filing.

A number of other large investors have also recently added to or reduced their stakes in the stock. Royal Bank of Canada grew its position in shares of Maximus by 146.2% during the first quarter. Royal Bank of Canada now owns 19,732 shares of the health services provider’s stock worth $1,345,000 after acquiring an additional 11,716 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its stake in Maximus by 0.6% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 34,476 shares of the health services provider’s stock valued at $2,351,000 after buying an additional 221 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its stake in Maximus by 7.0% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 180,690 shares of the health services provider’s stock worth $12,321,000 after purchasing an additional 11,754 shares during the period. Jane Street Group LLC grew its holdings in shares of Maximus by 941.2% during the first quarter. Jane Street Group LLC now owns 98,273 shares of the health services provider’s stock valued at $6,701,000 after buying an additional 88,835 shares in the last quarter. Finally, Sivia Capital Partners LLC purchased a new stake in shares of Maximus in the second quarter worth approximately $204,000. 97.21% of the stock is currently owned by institutional investors.

Insider Activity at Maximus

In other news, CEO Bruce Caswell purchased 3,175 shares of the stock in a transaction that occurred on Tuesday, February 10th. The stock was bought at an average cost of $78.45 per share, for a total transaction of $249,078.75. Following the acquisition, the chief executive officer directly owned 328,013 shares of the company’s stock, valued at $25,732,619.85. This represents a 0.98% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, CFO David Mutryn purchased 1,000 shares of Maximus stock in a transaction that occurred on Monday, February 9th. The shares were acquired at an average price of $75.62 per share, for a total transaction of $75,620.00. Following the acquisition, the chief financial officer owned 40,037 shares in the company, valued at $3,027,597.94. This trade represents a 2.56% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. 1.80% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

MMS has been the topic of several analyst reports. Wall Street Zen lowered shares of Maximus from a “buy” rating to a “hold” rating in a report on Monday, February 23rd. Weiss Ratings lowered shares of Maximus from a “buy (b)” rating to a “hold (c+)” rating in a research report on Tuesday, February 24th. Finally, Zacks Research upgraded Maximus from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, December 30th. One investment analyst has rated the stock with a Strong Buy rating and one has assigned a Hold rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Buy”.

Maximus Trading Down 4.9%

Shares of MMS stock opened at $73.49 on Wednesday. The company’s fifty day simple moving average is $85.31 and its two-hundred day simple moving average is $85.96. The company has a debt-to-equity ratio of 0.88, a current ratio of 2.34 and a quick ratio of 2.34. Maximus, Inc. has a 1 year low of $64.68 and a 1 year high of $100.00. The stock has a market capitalization of $4.01 billion, a price-to-earnings ratio of 11.19 and a beta of 0.59.

Maximus (NYSE:MMS) last posted its earnings results on Thursday, February 5th. The health services provider reported $1.85 earnings per share for the quarter, topping analysts’ consensus estimates of $1.84 by $0.01. Maximus had a net margin of 6.92% and a return on equity of 25.30%. The business had revenue of $1.35 billion for the quarter, compared to analyst estimates of $1.37 billion. During the same quarter in the prior year, the firm posted $1.61 EPS. Maximus’s revenue was down 4.1% on a year-over-year basis. Maximus has set its FY 2026 guidance at 8.050-8.350 EPS. As a group, analysts anticipate that Maximus, Inc. will post 6.15 earnings per share for the current year.

Maximus Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Monday, March 2nd. Investors of record on Friday, February 13th were given a $0.33 dividend. This represents a $1.32 dividend on an annualized basis and a yield of 1.8%. The ex-dividend date was Friday, February 13th. This is a positive change from Maximus’s previous quarterly dividend of $0.30. Maximus’s dividend payout ratio is presently 20.09%.

About Maximus

Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.